Results 61 to 70 of about 28,076 (179)
Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact [PDF]
Objective To examine the psychosocial impact of testing positive for high risk human papillomavirus (HPV) among women attending primary cervical screening.Design Cross sectional survey.Measures were taken at baseline and one week after the receipt of HPV
Cadman, L +5 more
core +1 more source
Gynecologic conditions in the context of incarceration: A scoping review
Abstract Background More than 740 000 people identified as female at intake were incarcerated globally as of 2022, reflecting a 60% global increase since the year 2000, with a concomitant increase in gynecologic conditions experienced behind bars.
Meredith K. Wise +6 more
wiley +1 more source
ABSTRACT Little is known about natural humoral immunity against recurrent HPV DNA detection. The objective of this study was to asses the risk of cervical HPV16 DNA detection in unvaccinated women according to HPV16 IgG and IgM seroreactivity status. We analyzed data from 618 women (mean age of 32 years) participating in the Ludwig–McGill cohort. Women
Andrea Trevisan +5 more
wiley +1 more source
Human Papillomavirus Infection: Prevention, Barriers to Vaccination, and the Need for Education [PDF]
While there is no known cure for HPV, prophylactic vaccination provides an effective method of primary prevention against HPV-related diseases. However, many females and males never receive the HPV vaccine as recommended.
Kessler, Theresa A
core +2 more sources
Human papillomavirus vaccination coverage in Luxembourg : implications of lowering and restricting target age groups [PDF]
Background: In Luxembourg, a national Human Papillomavirus (HPV) vaccination programme was introduced in 2008, targeting 12-17 year old girls offering a choice of bivalent or quadrivalent vaccine free of charge.
Arbyn, Marc +3 more
core +2 more sources
Topical Imiquimod for Oral Cavity Leukoplakia and Dysplasia: A Scoping Review
Abstract Objective Imiquimod, a toll‐like receptor 7 agonist, is currently FDA‐approved for treatment of actinic keratoses, superficial BCC, and external genital warts. It has also demonstrated promise in off‐label use in the treatment of oral cavity leukoplakia and dysplasia.
Megan K. Scharner +3 more
wiley +1 more source
Verruciform Xanthoma Within the Cyst Lining of Hidradenitis Suppurativa
ABSTRACT Verruciform xanthoma (VX) is a rare lesion most often seen in the oral mucosa or anogenital region, most commonly characterized histologically by verrucous epithelial hyperplasia and foamy histiocytes in the papillary dermis. While VX has been reported in association with inflammatory dermatoses such as lichen planus and lichen sclerosus, its ...
Deaquan Nichols +4 more
wiley +1 more source
Summary The occurrence of Aural Plaques (AP) in horses, attributed to infection with Equus caballus Papillomavirus (EcPV), has become increasingly prevalent in equine breeding populations. Major challenges in managing this condition include genetic susceptibility to the virus, significant variability in individual immune responses among horses and the ...
E. Bastianetto +6 more
wiley +1 more source
Genital warts treatment: Beyond imiquimod
Genital warts are one of the most common sexually transmitted diseases worldwide. The disease is a result of infection with low-risk types of human papillomaviruses, mostly type 6 and 11.
Jianwei Yuan +6 more
doaj +1 more source
Topical photodynamic therapy for genital warts: Systematic review and meta‐analysis
High recurrence rate and adverse effects were common shortcomings in treatments for genital warts, but a number of clinical studies have found that photodynamic therapy (PDT) had some unique superiority compared to other treatments.
Zhi Cao +5 more
doaj +1 more source

